A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2007
11/07/2007	CN101066982A Amino acid-glucose derivative 99m TC compound and its prepn process
11/06/2007	US7291628 Treatment of cocaine abuse using N-substituted derivatives of morphinan
11/06/2007	US7291606 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging
11/06/2007	US7291598 Nanoparticles for protein drug delivery
11/06/2007	CA2079881C Nucleotidic sequences coding for variable regions of .beta. chains of human t lymphocite receptors, corresponding peptidic segments and diagnostic and therapeutic applications
11/01/2007	WO2007124198A2 Biopolymer system for tissue sealing
11/01/2007	WO2007123934A2 Aryl bidentate isonitriles and their uses
11/01/2007	WO2007122820A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007	WO2007122488A2 Radiofluorinated compounds and their preparation
11/01/2007	WO2007122291A1 Titanocenes for labelling biospecific binding reactants
11/01/2007	US20070255117 Enhanced ultrasound detection with temperature-dependent contrast agents
11/01/2007	US20070255043 MN gene and protein
11/01/2007	US20070254316 Peptides for targeting the prostate specific membrane antigen
11/01/2007	US20070253902 Treatment for inflammatory bowel disease
11/01/2007	US20070253901 Atherosclerosis genes and related reagents and methods of use thereof
11/01/2007	US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007	US20070253899 Dual Function Polymer Micelles
11/01/2007	US20070253898 Polymer based radionuclide containing particulate material
11/01/2007	US20070253897 Includes a radionuclide containment composition dispenser and a sorption based media container; containment composition is a mixture of a clay mineral and water
11/01/2007	US20070253896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
11/01/2007	CA2650699A1 Diagnostic agent and therapeutic agent for pancreatic cancer
10/2007
10/31/2007	EP1848464A1 Compositions and methods for multimodal imaging
10/31/2007	EP1315777B1 Degradable polyacetal polymers
10/31/2007	EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007	CN101065152A Upar-targeting contrast agents
10/30/2007	US7288534 Sphingomyelin enhancement of tumor therapy
10/30/2007	US7288255 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
10/30/2007	CA2171218C Metallospheres and superclusters
10/25/2007	WO2007120251A2 Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters
10/25/2007	WO2007119103A1 Labeled macrophages and methods of use thereof
10/25/2007	WO2007002540A3 Radiolabeled-pegylation of ligands for use as imaging agents
10/25/2007	WO2006002122A3 Stabilized and lyophilized radiopharmaceutical agents
10/25/2007	US20070249816 Methods for carbon istope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
10/25/2007	US20070249641 Adenosine a3 receptor modulators
10/25/2007	US20070248540 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
10/25/2007	US20070248539 AgRM2 antigen
10/25/2007	US20070248538 Cytotoxicity mediation of cells evidencing surface expression of CD44
10/25/2007	US20070248537 Compositions and Methods for Cellular Imaging and Therapy
10/25/2007	US20070248536 conjugate between a polypeptide based on ubiquitin and a functional component wherein the respective polypeptide molecule has a binding property for the specific binding to a ligand which is altered as compared to the wild type polypeptide; diagnostic kit
10/25/2007	US20070248535 Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
10/25/2007	US20070248534 Auger effect-based cancer therapy method
10/25/2007	US20070248533 Stabilized and Lyophilized Radiopharmaceutical Agents For Destroying Tumors
10/25/2007	CA2634666A1 Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters
10/24/2007	EP1846043A2 Bridgehead radiolabelled compounds and methods of using the same
10/24/2007	EP1846042A2 Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
10/24/2007	CN101060886A Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
10/24/2007	CN101060865A A method of diagnosing prodromal forms of diseases associated with amyloid deposition
10/23/2007	US7285527 Tumor radiosensitization using gene therapy
10/18/2007	WO2007118249A2 Personal electronic device carrier
10/18/2007	WO2007118214A2 Antibody compositions and methods for treatment of neoplastic disease
10/18/2007	WO2007094818A3 Novel hiv targets
10/18/2007	US20070244316 Optically pure and enriched isomers of chelating ligands and contrast agents
10/18/2007	US20070243139 A dimer of two polypeptides having specificity andreceptivity for different epitopes on a protein-tyrosinekinase receptor; linked by spacers; synergistic; contrast agents for radition imaging and therapy; biodrugs; hepatocyte growth factor receptor/cMET complex target; antitumor, -carcinogenic agents
10/18/2007	US20070243134 Receptor Selective Cannabimimetic Aminoalkylindoles
10/18/2007	US20070243133 Imaging phosphatidylserine exposure on a nucleated cell by administering a radionuclide-labeled annexin (Tc99m linked to annexin via hydrazinonicotinamide) and measuring radiation emission (gamma rays) from the localized radionuclide; tracking changes in intensity of radiation emission over time
10/18/2007	US20070243132 Transdermal delivery of pharmaceutical agents
10/18/2007	US20070243131 Biopolymer system for tissue sealing
10/18/2007	US20070243130 Biopolymer system for tissue sealing
10/18/2007	DE102004035916B4 Verfahren zur isotopenselektiven Bestimmung von Stickstoffmonoxid-Konzentrationen A method for isotopically selective determination of nitric oxide concentrations
10/18/2007	CA2651911A1 Anti ku70 internalizing antibodies
10/17/2007	EP1844794A1 Silicon implants comprising a radionucleotide and/or a cytotoxic drug and their use in cancer treatment
10/17/2007	EP1843792A1 Stabilisation of radiopharmaceutical precursors
10/17/2007	EP1276770B1 Proteins with a high immunoreactivity and a method for the production thereof
10/17/2007	CN200960355Y Pipeline support capable of bearing minitype radioactive particle source
10/17/2007	CN101056859A Quinoline derivatives as isotope labeling for adenosine a3 receptor ligand
10/17/2007	CN100343239C IL-5 inhibiting azauracil pyrimidine derivatives
10/17/2007	CN100342916C Biodegradable medical material marker and preparation thereof
10/16/2007	US7282567 Monoclonal antibody hPAM4
10/16/2007	US7282494 Heteroaryl diazacycloalkanes, their preparation and use
10/16/2007	US7282194 Nanoparticles for protein drug delivery
10/16/2007	CA2289585C Novel imaging agents and methods for the preparation and use thereof
10/11/2007	WO2007113386A1 Peptide conjugates
10/11/2007	WO2007113385A1 Diagnostic and therapeutic agents
10/11/2007	WO2007008704A3 Melanocortin receptor ligands
10/11/2007	US20070238767 e.g. 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid; ferrochelatase; thalassemia, anemia; diagnosing and treating pathological conditions associated with excess of trivalent metals (such as Fe, Al and Cr)
10/11/2007	US20070237714 Diagnosis and treatment of tumors
10/11/2007	US20070237713 PCan065 Antibody Compositions and Methods of Use
10/11/2007	US20070237712 Methods of Redistributing Apical Target Antigens to Detect and Treat Cellular Proliferative Disease
10/11/2007	US20070237711 Method of Increasing Radiation Sensitivity by Inhibition of Beta One Integrin
10/10/2007	EP1841790A2 Ephb receptor-binding peptides
10/10/2007	EP1841468A2 Laser activated nanothermolysis of cells
10/10/2007	EP1841467A2 Combination cancer therapy with anti-psma antibodies
10/10/2007	EP1841466A2 Agents for therapy efficacy monitoring and deep tissue imaging
10/10/2007	EP1240396B1 A ventilating device for ventilating through a ridge
10/10/2007	CN101052423A Radiolabeling insulin
10/10/2007	CN100341883C Calcium complex of phosphorus contg. ethylenediamine derivs.
10/10/2007	CN100341582C Medicine of vasoactive peptide derivative containing SN3 ligand and its making method
10/10/2007	CN100341572C Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
10/09/2007	US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007	US7279150 Nanoparticle emulsion; magnetic resonance imaging; antiinflammatory agents; antitumor agents
10/09/2007	US7279149 Amino acid composition with increased blood brain barrier permeability
10/04/2007	WO2007111020A1 Composition for preparation of radioactive pharmaceutical for diagnosis of regional cerebral blood flow
10/04/2007	WO2007038641A3 Methods and therapies for treating inflammatory conditions with exposed collagen
10/04/2007	WO2007030012A3 Extracellular matrix imaging
10/04/2007	US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007	US20070231266 Diagnosis of macrophage mediated disease
10/04/2007	US20070231258 Peptide conjugates
10/04/2007	US20070231257 Radiodiagnosis, radiotherapy
10/04/2007	US20070231256 Compositions and methods for detecting and treating tumors containing acidic areas
10/03/2007	EP1838354A2 Radioactive device

1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 243